Study Type : Interventional (Clinical Trial) 1 Estimated Enrollment : 360 participants 2 Allocation: Randomized 3 Intervention Model: Parallel Assignment 4 Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) 5 Primary Purpose: Treatment 6 Official Title: A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris 7 Actual Study Start Date : June 26, 2018 8 Estimated Primary Completion Date : February 2019 9 Estimated Study Completion Date : March 2019
Ann: Investor Presentation, page-117
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $696.8M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.5¢ | 37.5¢ | $4.475M | 11.63M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 37310 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.5¢ | 54981 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |